Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemorrhagic Risk Conditions”

120 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 120 results

Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Not applicableStudy completedNCT02371330
What this trial is testing

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study

Who this might be right for
Thrombocytopenia
Karolinska Institutet 76
Early research (Phase 1)UnknownNCT00769613
What this trial is testing

Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections

Who this might be right for
Cancer
Milton S. Hershey Medical Center 20
Not applicableLooking for participantsNCT07411079
What this trial is testing

Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage

Who this might be right for
Intracerebral HemorrhageHemorrhagic Risk ConditionsBleeding Disorders
University Hospital, Lille 1,126
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Large-scale testing (Phase 3)Looking for participantsNCT05198960
What this trial is testing

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

Who this might be right for
Polycythemia VeraEssential ThrombocythemiaPrefibrotic/Early Primary Myelofibrosis+2 more
University Hospital, Brest 1,308
Not applicableEnded earlyNCT00949052
What this trial is testing

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 1,000
Not applicableActive Not RecruitingNCT00039676
What this trial is testing

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Who this might be right for
Waldenstrom MacroglobulinemiaChronic Lymphocytic LeukemiaHodgkin Disease+2 more
National Cancer Institute (NCI) 1,836
Not applicableActive Not RecruitingNCT05844033
What this trial is testing

Biomarker for Infection Risk in CLL and MM

Who this might be right for
Multiple MyelomaChronic Lymphocytic Leukemia
Massachusetts General Hospital 150
Testing effectiveness (Phase 2)Study completedNCT00533923
What this trial is testing

Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders

Who this might be right for
AMLALLCLL+6 more
Beth Israel Deaconess Medical Center 25
Not applicableUnknownNCT03311321
What this trial is testing

Vitamin K to Slow Progression of Cardiovascular Disease Risk in Hemodialysis Patients

Who this might be right for
Cardiovascular DiseasesChronic Kidney Disease Stage 3Chronic Kidney Disease Stage 4+3 more
Augusta University 60
Not applicableNot Yet RecruitingNCT07173075
What this trial is testing

Evaluation of the Relationship Between Muscle Mass Measured by Bioelectrical Impedance Analysis and the Risk of Hemorrhagic Events Under Direct Oral Anticoagulants in the Elderly

Who this might be right for
Direct Oral AnticoagulantHemmorhageElderly+3 more
University Hospital, Clermont-Ferrand 110
Testing effectiveness (Phase 2)Study completedNCT03601078
What this trial is testing

An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 312
Not applicableNot Yet RecruitingNCT07278648
What this trial is testing

High-risk Antithrombotic Drugs at Discharge and Consultation for Hemorrhagic or Thromboembolic Events in the Emergency Department

Who this might be right for
Acute Disease
Consorci Sanitari de l'Alt Penedès i Garraf 150
Not applicableStudy completedNCT03421184
What this trial is testing

Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus

Who this might be right for
Lupus ErythematosusRheumatoid ArthritisAutoimmune Thrombocytopenia
University Hospital, Bordeaux 63
Early research (Phase 1)Study completedNCT03018223
What this trial is testing

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT

Who this might be right for
Non-Hodgkin's LymphomaAcute Leukemia in RemissionChronic Myeloid Leukemia+5 more
H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Ended earlyNCT00818961
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Northside Hospital, Inc. 36
Not applicableNot Yet RecruitingNCT07580469
What this trial is testing

Platelets and Extracorporeal Membrane Oxygenation Veno-venous

Who this might be right for
Extracorporeal Membrane Oxygenation ComplicationHemorrhageBlood Platelet Disorder+1 more
University Hospital, Toulouse 40
Large-scale testing (Phase 3)Looking for participantsNCT07393282
What this trial is testing

Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

Who this might be right for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Regeneron Pharmaceuticals 270
Load More Results